Evaluation of the Effect of Blood Glucose Level and Body Mass Index on Optic Nerve Sheath Diameter and Visual Acuity of Apparently Normal Subjects in Nnewi Metropolis

Background and Aim: The optic nerve sheath diameter (ONSD) serves as a non-invasive sonographic surrogate marker for monitoring intracranial pressure (ICP) dynamics, while visual acuity (VA) reflects the spatial resolving power of the visual pathway. Systemic metabolic indicators such as Body Mass Index (BMI) and fasting blood Glucose (FBG) influence microvascular and neurological health, yet their baseline effects on ocular microstructures in healthy African populations require local reference characterization. This study evaluated the effect of blood glucose levels and BMI on the ONSD and visual acuity of apparently normal adults in Nnewi metropolis, Anambra State, Nigeria.

Materials and Methods: A prospective, cross-sectional, community-based study was conducted among 400 apparently healthy adults aged 18–60 years recruited via quota sampling across the four communities of Nnewi (Otolo, Uruagu, Umudim, and Nnewichi). Anthropometric parameters were measured to compute BMI, venous/capillary fasting blood samples were analyzed for FBG, and distance visual acuity was assessed at 6 meters using a Snellen chart and converted to LogMAR values. Transorbital B-mode ultrasonography using a 7–12 MHz linear array transducer measured ONSD 3 mm posterior to the retina–optic nerve junction in transverse and longitudinal planes. Data were analyzed using MedCalc statistical software 23.2.5 via descriptive statistics, Kendall’s tau correlation and Kruskal-Wallis H test at p < 0.05.

Results: The cohort comprised 278 females (69.5%) and 122 males (30.5%). Composite ONSD demonstrated high bilateral symmetry with a mean of 4.7 ± 0.7 mm (median: 4.8 mm; 75th percentile: 5.0 mm) and showed no statistically significant variation across underweight (4.6 ± 0.6 mm), normal weight (4.7 ± 0.7 mm), and overweight/obese (4.7 ± 0.7 mm) categories (p = 0.606) or between genders (p > 0.05). Median LogMAR values were -0.02 (right) and -0.04 (left), with no significant differences across BMI groups (p > 0.05). Conversely, mean FBG increased progressively with BMI from 90.4 ± 24.7 mg/dL in underweight subjects to 91.6 ± 27.8 mg/dL in normal-weight subjects and 101.2 ± 37.4 mg/dL in overweight/obese subjects (p = 0.007; Kruskal-Wallis p = 0.000011), correlating positively with BMI (τ = 0.198, p < 0.0001). Negligible correlations were observed between FBG and composite ONSD (τ = 0.0511, p = 0.1273), right LogMAR (τ = 0.0507, p = 0.1298), and left LogMAR (τ = 0.00823, p = 0.8062).

Conclusion: Baseline normative ONSD values for healthy adults in Nnewi metropolis were established at 4.7 ± 0.7 mm. Although elevated BMI significantly drives higher fasting blood glucose levels, neither BMI nor baseline FBG exerts a statistically significant structural impact on ONSD or immediate functional impact on visual acuity in apparently healthy adults, confirming ONSD as an anthropometrically stable diagnostic biomarker.

 

Keywords: Body Mass Index, Fasting Blood Glucose, Intracranial Pressure, Ocular Ultrasonography, Optic Nerve Sheath Diameter, Visual Acuity.